ReP USP - Resultado da busca

Artigo de periodico
Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation (2024)
Bashir, Bushra; Alam, Shahbaz; Khandale, Nikhil; Birla, Devendra; Vishwas, Sukriti ; Pandey, Narendra Kumar; Gupta, Gaurav; Paudel, Keshav Raj ; Dureja, Harish; Kumar, Puneet; Singh, Thakur Gurjeet; Kuppusamy, Gowthamarajan; Zacconi, Flavia C; Pinto, Terezinha de Jesus Andreoli ; Dhanasekaran, Muralikrishnan; Gulati, Monica; Dua, Kamal ; Singh, Sachin Kumar
Fonte: Ageing Research Reviews. Unidade: FCF
Assuntos: DOENÇAS NEURODEGENERATIVAS, ENVELHECIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASHIR, Bushra et al. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, v. 95, p. 1-16 art. 102236, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.arr.2024.102236. Acesso em: 03 jun. 2024.
APA
Bashir, B., Alam, S., Khandale, N., Birla, D., Vishwas, S., Pandey, N. K., et al. (2024). Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, 95, 1-16 art. 102236. doi:10.1016/j.arr.2024.102236
NLM
Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2024 jun. 03 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236
Vancouver
Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2024 jun. 03 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236
Artigo de periodico
Recent advances in mitigating biofilms on medical devices (2024)
Lirio, Adriana Cogo Malgueiro ; Ghisleni, Daniela Dal Molim ; Chellappan, Dinesh Kumar ; Dua, Kamal ; Pinto, Terezinha de Jesus Andreoli
Fonte: ISAR Journal of Medical and Pharmaceutical Science. Unidade: FCF
Assuntos: BIOFILMES, VIRULÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIRIO, Adriana Cogo Malgueiro et al. Recent advances in mitigating biofilms on medical devices. ISAR Journal of Medical and Pharmaceutical Science, v. 2, p. 19-22, 2024Tradução . . Disponível em: https://dx.doi.org/10.5281/zenodo.10876918. Acesso em: 03 jun. 2024.
APA
Lirio, A. C. M., Ghisleni, D. D. M., Chellappan, D. K., Dua, K., & Pinto, T. de J. A. (2024). Recent advances in mitigating biofilms on medical devices. ISAR Journal of Medical and Pharmaceutical Science, 2, 19-22. doi:10.5281/zenodo.10876918
NLM
Lirio ACM, Ghisleni DDM, Chellappan DK, Dua K, Pinto T de JA. Recent advances in mitigating biofilms on medical devices [Internet]. ISAR Journal of Medical and Pharmaceutical Science. 2024 ; 2 19-22.[citado 2024 jun. 03 ] Available from: https://dx.doi.org/10.5281/zenodo.10876918
Vancouver
Lirio ACM, Ghisleni DDM, Chellappan DK, Dua K, Pinto T de JA. Recent advances in mitigating biofilms on medical devices [Internet]. ISAR Journal of Medical and Pharmaceutical Science. 2024 ; 2 19-22.[citado 2024 jun. 03 ] Available from: https://dx.doi.org/10.5281/zenodo.10876918
Artigo de periodico
Two-dimensional gel and shotgun proteomics approaches for the comparative evaluation of genetically modified maize (2024)
Santos-Donado, Priscila Robertina dos ; Donado-Pestana, Carlos Mario ; Rondán-Sanabria, Gerby Giovanna ; Pauletti, Bianca A; Kawahara, Rebeca; Palmisano, Giuseppe ; Finardi-Filho, Flavio
Fonte: Journal of Food Measurement and Characterization. Unidades: ICB, FCF, ESALQ
Assuntos: ALIMENTOS TRANSGÊNICOS, COMPOSIÇÃO QUÍMICA, MILHO, PLANTAS TRANSGÊNICAS, PROTEÔMICA, SEGURANÇA ALIMENTAR, VARIEDADES VEGETAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS-DONADO, Priscila Robertina dos et al. Two-dimensional gel and shotgun proteomics approaches for the comparative evaluation of genetically modified maize. Journal of Food Measurement and Characterization, p. 1-21, 2024Tradução . . Disponível em: https://doi.org/10.1007/s11694-024-02397-x. Acesso em: 03 jun. 2024.
APA
Santos-Donado, P. R. dos, Donado-Pestana, C. M., Rondán-Sanabria, G. G., Pauletti, B. A., Kawahara, R., Palmisano, G., & Finardi-Filho, F. (2024). Two-dimensional gel and shotgun proteomics approaches for the comparative evaluation of genetically modified maize. Journal of Food Measurement and Characterization, 1-21. doi:10.1007/s11694-024-02397-x
NLM
Santos-Donado PR dos, Donado-Pestana CM, Rondán-Sanabria GG, Pauletti BA, Kawahara R, Palmisano G, Finardi-Filho F. Two-dimensional gel and shotgun proteomics approaches for the comparative evaluation of genetically modified maize [Internet]. Journal of Food Measurement and Characterization. 2024 ; 1-21.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s11694-024-02397-x
Vancouver
Santos-Donado PR dos, Donado-Pestana CM, Rondán-Sanabria GG, Pauletti BA, Kawahara R, Palmisano G, Finardi-Filho F. Two-dimensional gel and shotgun proteomics approaches for the comparative evaluation of genetically modified maize [Internet]. Journal of Food Measurement and Characterization. 2024 ; 1-21.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s11694-024-02397-x
Monografia/livro
Immunotherapy against lung cancer: emerging opportunities and challenges (2024)
Bhatt, Shvetank ; Eri, Rajaraman; Goh, Bey Hing ; Paudel, Keshav Raj ; Pinto, Terezinha de Jesus Andreoli ; Dua, Kamal
Unidade: FCF
Assuntos: IMUNOTERAPIA, NEOPLASIAS PULMONARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BHATT, Shvetank et al. Immunotherapy against lung cancer: emerging opportunities and challenges. . Singapore: Springer. . Acesso em: 03 jun. 2024. , 2024
APA
Bhatt, S., Eri, R., Goh, B. H., Paudel, K. R., Pinto, T. de J. A., & Dua, K. (2024). Immunotherapy against lung cancer: emerging opportunities and challenges. Singapore: Springer.
NLM
Bhatt S, Eri R, Goh BH, Paudel KR, Pinto T de JA, Dua K. Immunotherapy against lung cancer: emerging opportunities and challenges. 2024 ;[citado 2024 jun. 03 ]
Vancouver
Bhatt S, Eri R, Goh BH, Paudel KR, Pinto T de JA, Dua K. Immunotherapy against lung cancer: emerging opportunities and challenges. 2024 ;[citado 2024 jun. 03 ]
Artigo de periodico
Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid (2024)
Zahm, Shelia ; Bonde, Jens Peter ; Chiu, Weihsueh A ; Hoppin, Jane ; Kanno, Jun ; Abdallah, Mohamed; Blystone, Chad R ; Calkins, Miriam M ; Dong, Guang Hui ; Dorman, David C; Fry, Rebecca; Guo, Huan; Haug, Line Småstuen ; Hofmann, Jonathan N. ; Iwasaki, Motoki; Machala, Miroslav ; Mancini, Francesca Romana ; Maria-Engler, Silvya Stuchi ; Møller, Peter Rsak ; Ng, Jack Chakmeng; Pallardy, Marc ; Post, Gloria B ; Salihovic, Samira ; Schlezinger, Jennifer ; Soshilov, Anatoly; Steenland, Kyle ; Steffensen, Inger Lise ; Tryndyak, Volodymyr ; White, Alexandra; Woskie, Susan
Fonte: The Lancet Oncology. Unidade: FCF
Assuntos: CARCINOGÊNESE, PRODUTOS QUÍMICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAHM, Shelia et al. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. The Lancet Oncology, v. 25, n. 1, p. 16-17, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/S1470-2045(23)00622-8. Acesso em: 03 jun. 2024.
APA
Zahm, S., Bonde, J. P., Chiu, W. A., Hoppin, J., Kanno, J., Abdallah, M., et al. (2024). Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. The Lancet Oncology, 25( 1), 16-17. doi:10.1016/S1470-2045(23)00622-8
NLM
Zahm S, Bonde JP, Chiu WA, Hoppin J, Kanno J, Abdallah M, Blystone CR, Calkins MM, Dong GH, Dorman DC, Fry R, Guo H, Haug LS, Hofmann JN, Iwasaki M, Machala M, Mancini FR, Maria-Engler SS, Møller PR, Ng JC, Pallardy M, Post GB, Salihovic S, Schlezinger J, Soshilov A, Steenland K, Steffensen IL, Tryndyak V, White A, Woskie S. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid [Internet]. The Lancet Oncology. 2024 ; 25( 1): 16-17.[citado 2024 jun. 03 ] Available from: https://dx.doi.org/10.1016/S1470-2045(23)00622-8
Vancouver
Zahm S, Bonde JP, Chiu WA, Hoppin J, Kanno J, Abdallah M, Blystone CR, Calkins MM, Dong GH, Dorman DC, Fry R, Guo H, Haug LS, Hofmann JN, Iwasaki M, Machala M, Mancini FR, Maria-Engler SS, Møller PR, Ng JC, Pallardy M, Post GB, Salihovic S, Schlezinger J, Soshilov A, Steenland K, Steffensen IL, Tryndyak V, White A, Woskie S. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid [Internet]. The Lancet Oncology. 2024 ; 25( 1): 16-17.[citado 2024 jun. 03 ] Available from: https://dx.doi.org/10.1016/S1470-2045(23)00622-8
Artigo de periodico
Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments (2023)
Lirio, Adriana Cogo Malgueiro ; Diaz, Victor A. Febo; Chellappan, Dinesh Kumar ; Dua, Kamal ; Lourenço, Felipe Rebello ; Pinto, Terezinha de Jesus Andreoli
Fonte: Journal of Pharmaceutical Innovation. Unidade: FCF
Assuntos: FÁRMACOS, MONITORAMENTO AMBIENTAL, CONTROLE DE PROCESSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIRIO, Adriana Cogo Malgueiro et al. Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments. Journal of Pharmaceutical Innovation, v. 18, p. 1362-1370, 2023Tradução . . Disponível em: https://doi.org/10.1007/s12247-023-09719-4. Acesso em: 03 jun. 2024.
APA
Lirio, A. C. M., Diaz, V. A. F., Chellappan, D. K., Dua, K., Lourenço, F. R., & Pinto, T. de J. A. (2023). Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments. Journal of Pharmaceutical Innovation, 18, 1362-1370. doi:10.1007/s12247-023-09719-4
NLM
Lirio ACM, Diaz VAF, Chellappan DK, Dua K, Lourenço FR, Pinto T de JA. Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments [Internet]. Journal of Pharmaceutical Innovation. 2023 ; 18 1362-1370.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12247-023-09719-4
Vancouver
Lirio ACM, Diaz VAF, Chellappan DK, Dua K, Lourenço FR, Pinto T de JA. Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments [Internet]. Journal of Pharmaceutical Innovation. 2023 ; 18 1362-1370.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s12247-023-09719-4
Artigo de periodico
Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells (2023)
Rubis, Gabriele De; Paudel, Keshav Raj ; Liu, Gang ; Agarwal, Vishwesh ; MacLoughlin, Ronan ; Pinto, Terezinha de Jesus Andreoli ; Singh, Sachin Kumar ; Adams, Jon ; Nammi, Srinivas ; Chellappan, Dinesh Kumar ; Oliver, Brian Gregory George ; Hansbro, Philip Michael; Dua, Kamal
Fonte: Toxicology in Vitro. Unidade: FCF
Assuntos: NANOPARTÍCULAS, CÉLULAS EPITELIAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUBIS, Gabriele De et al. Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells. Toxicology in Vitro, v. 92, p. 1-9 art. 105660, 2023Tradução . . Disponível em: https://dx.doi.org/10.1016/j.tiv.2023.105660. Acesso em: 03 jun. 2024.
APA
Rubis, G. D., Paudel, K. R., Liu, G., Agarwal, V., MacLoughlin, R., Pinto, T. de J. A., et al. (2023). Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells. Toxicology in Vitro, 92, 1-9 art. 105660. doi:10.1016/j.tiv.2023.105660
NLM
Rubis GD, Paudel KR, Liu G, Agarwal V, MacLoughlin R, Pinto T de JA, Singh SK, Adams J, Nammi S, Chellappan DK, Oliver BGG, Hansbro PM, Dua K. Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells [Internet]. Toxicology in Vitro. 2023 ; 92 1-9 art. 105660.[citado 2024 jun. 03 ] Available from: https://dx.doi.org/10.1016/j.tiv.2023.105660
Vancouver
Rubis GD, Paudel KR, Liu G, Agarwal V, MacLoughlin R, Pinto T de JA, Singh SK, Adams J, Nammi S, Chellappan DK, Oliver BGG, Hansbro PM, Dua K. Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells [Internet]. Toxicology in Vitro. 2023 ; 92 1-9 art. 105660.[citado 2024 jun. 03 ] Available from: https://dx.doi.org/10.1016/j.tiv.2023.105660
Artigo de periodico
1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors (2023)
Tavares, Maurício Temotheo ; Krüger, Arne ; Yan, Sun Liu Rei ; Waitman, Karoline de Barros ; Gomes, Vinícius de Morais ; Oliveira, Daffiny Sumam de ; Paz, Franciarli ; Hilscher, Sebastian ; Schutkowski, Mike ; Sippl, Wolfgang ; Ruiz, Claudia; Toledo, Mônica Franco Zannini Junqueira ; Poso, Antti ; Cameron, Michael D. ; Bannister, Thomas D. ; Kronenberger, Thales ; Parise Filho, Roberto ; Hassimotto, Neuza Mariko Aymoto ; Machado Neto, João Agostinho ; Palmisano, Giuseppe ; Wrenger, Carsten
Fonte: Scientific Reports. Unidades: FCF, ICB
Assuntos: FARMACOLOGIA, PARASITOLOGIA, ANTIMALÁRICOS, EPIGÊNESE GENÉTICA, ÁCIDO FÓLICO, ANTAGONISTAS, PROTEÍNAS, PROTEÍNAS RECOMBINANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Maurício Temotheo et al. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors. Scientific Reports, v. 13, n. 1, p. 20 , 2023Tradução . . Disponível em: https://doi.org/10.1038/s41598-023-47959-z. Acesso em: 03 jun. 2024.
APA
Tavares, M. T., Krüger, A., Yan, S. L. R., Waitman, K. de B., Gomes, V. de M., Oliveira, D. S. de, et al. (2023). 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors. Scientific Reports, 13( 1), 20 . doi:10.1038/s41598-023-47959-z
NLM
Tavares MT, Krüger A, Yan SLR, Waitman K de B, Gomes V de M, Oliveira DS de, Paz F, Hilscher S, Schutkowski M, Sippl W, Ruiz C, Toledo MFZJ, Poso A, Cameron MD, Bannister TD, Kronenberger T, Parise Filho R, Hassimotto NMA, Machado Neto JA, Palmisano G, Wrenger C. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors [Internet]. Scientific Reports. 2023 ; 13( 1): 20 .[citado 2024 jun. 03 ] Available from: https://doi.org/10.1038/s41598-023-47959-z
Vancouver
Tavares MT, Krüger A, Yan SLR, Waitman K de B, Gomes V de M, Oliveira DS de, Paz F, Hilscher S, Schutkowski M, Sippl W, Ruiz C, Toledo MFZJ, Poso A, Cameron MD, Bannister TD, Kronenberger T, Parise Filho R, Hassimotto NMA, Machado Neto JA, Palmisano G, Wrenger C. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors [Internet]. Scientific Reports. 2023 ; 13( 1): 20 .[citado 2024 jun. 03 ] Available from: https://doi.org/10.1038/s41598-023-47959-z
Artigo de periodico
Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice (2023)
Santos, Yasmin da Silva ; Oliveira, Danielle Bruna Leal de ; Palmisano, Giuseppe ; Wrenger, Carsten ; Covas, Dimas Tadeu ; Curi, Rui ; Marinho, Claudio Romero Farias ; Durigon, Edison Luiz ; Epiphanio, Sabrina
Fonte: Viruses. Unidades: ICB, FMRP, FCF
Assuntos: MICROBIOLOGIA, PARASITOLOGIA, COVID-19, VARIAÇÃO GENÉTICA, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, VIRULÊNCIA, CORONAVIRUS, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Yasmin da Silva et al. Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice. Viruses, v. 15, n. 4, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.3390/v15040999. Acesso em: 03 jun. 2024.
APA
Santos, Y. da S., Oliveira, D. B. L. de, Palmisano, G., Wrenger, C., Covas, D. T., Curi, R., et al. (2023). Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice. Viruses, 15( 4), 1-16. doi:10.3390/v15040999
NLM
Santos Y da S, Oliveira DBL de, Palmisano G, Wrenger C, Covas DT, Curi R, Marinho CRF, Durigon EL, Epiphanio S. Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice [Internet]. Viruses. 2023 ; 15( 4): 1-16.[citado 2024 jun. 03 ] Available from: https://doi.org/10.3390/v15040999
Vancouver
Santos Y da S, Oliveira DBL de, Palmisano G, Wrenger C, Covas DT, Curi R, Marinho CRF, Durigon EL, Epiphanio S. Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice [Internet]. Viruses. 2023 ; 15( 4): 1-16.[citado 2024 jun. 03 ] Available from: https://doi.org/10.3390/v15040999
Monografia/livro
Natural polymeric materials based drug delivery systems in lung diseases (2023)
Dureja, Harish; Adams, Jon; Löbenberg, Raimar ; Pinto, Terezinha de Jesus Andreoli ; Dua, Kamal
Unidade: FCF
Assuntos: DOENÇAS RESPIRATÓRIAS, LIPOSSOMOS, FARMACOCINÉTICA, NANOPARTÍCULAS, BIOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUREJA, Harish et al. Natural polymeric materials based drug delivery systems in lung diseases. . Singapore: Springer. Disponível em: https://doi.org/10.1007/978-981-19-7656-8. Acesso em: 03 jun. 2024. , 2023
APA
Dureja, H., Adams, J., Löbenberg, R., Pinto, T. de J. A., & Dua, K. (2023). Natural polymeric materials based drug delivery systems in lung diseases. Singapore: Springer. doi:10.1007/978-981-19-7656-8
NLM
Dureja H, Adams J, Löbenberg R, Pinto T de JA, Dua K. Natural polymeric materials based drug delivery systems in lung diseases [Internet]. 2023 ;[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/978-981-19-7656-8
Vancouver
Dureja H, Adams J, Löbenberg R, Pinto T de JA, Dua K. Natural polymeric materials based drug delivery systems in lung diseases [Internet]. 2023 ;[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/978-981-19-7656-8
Artigo de periodico
Exploring the multifaceted potential of chlorogenic acid: journey from nutraceutical to nanomedicine (2023)
Singh, Sachin Kumar ; Thakur, Kiran ; Sharma, Vishal; Saini, Mamta ; Sharma, Diksha; Vishwas, Sukriti ; Kakoty, Violina ; Pal, Rashmi Saxena ; Chaitanya, M. V. N. L; Babu, Malakapogu Ravindra ; Gupta, Saurabh ; Rehman, Zia Ur; Smriti; Singla, Madhav ; Gupta, Gaurav ; Jakhmola, Vikash; Pinto, Terezinha de Jesus Andreoli ; Kumbhar, Popat; Disouza, John; Patravale, Vandana ; Dua, Kamal ; Gadewar, Manoj M
Fonte: South African Journal of Botany. Unidade: FCF
Assuntos: CAFÉ, ANTIOXIDANTES, ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SINGH, Sachin Kumar et al. Exploring the multifaceted potential of chlorogenic acid: journey from nutraceutical to nanomedicine. South African Journal of Botany, v. 159, p. 658-677, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.sajb.2023.06.038. Acesso em: 03 jun. 2024.
APA
Singh, S. K., Thakur, K., Sharma, V., Saini, M., Sharma, D., Vishwas, S., et al. (2023). Exploring the multifaceted potential of chlorogenic acid: journey from nutraceutical to nanomedicine. South African Journal of Botany, 159, 658-677. doi:10.1016/j.sajb.2023.06.038
NLM
Singh SK, Thakur K, Sharma V, Saini M, Sharma D, Vishwas S, Kakoty V, Pal RS, Chaitanya MVNL, Babu MR, Gupta S, Rehman ZU, Smriti, Singla M, Gupta G, Jakhmola V, Pinto T de JA, Kumbhar P, Disouza J, Patravale V, Dua K, Gadewar MM. Exploring the multifaceted potential of chlorogenic acid: journey from nutraceutical to nanomedicine [Internet]. South African Journal of Botany. 2023 ; 159 658-677.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.sajb.2023.06.038
Vancouver
Singh SK, Thakur K, Sharma V, Saini M, Sharma D, Vishwas S, Kakoty V, Pal RS, Chaitanya MVNL, Babu MR, Gupta S, Rehman ZU, Smriti, Singla M, Gupta G, Jakhmola V, Pinto T de JA, Kumbhar P, Disouza J, Patravale V, Dua K, Gadewar MM. Exploring the multifaceted potential of chlorogenic acid: journey from nutraceutical to nanomedicine [Internet]. South African Journal of Botany. 2023 ; 159 658-677.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.sajb.2023.06.038
Artigo de periodico
Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles (2023)
Awasthi, Rajendra ; Singh, Anurag Kumar ; Mishra, Gaurav ; Maurya, Anand ; Dhiman, Neerupma ; Kharkwal, Harsha ; Sharma, Bhupesh ; Jha, Niraj Kumar ; Dua, Kamal ; Pinto, Terezinha de Jesus Andreoli ; Kulkarni, Giriraj T
Fonte: Letters in Drug Design & Discovery. Unidade: FCF
Assuntos: NEOPLASIAS PULMONARES, NANOTECNOLOGIA, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AWASTHI, Rajendra et al. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles. Letters in Drug Design & Discovery, v. 20, n. 5, p. 499-516, 2023Tradução . . Disponível em: https://doi.org/10.2174/1570180819666220510133408. Acesso em: 03 jun. 2024.
APA
Awasthi, R., Singh, A. K., Mishra, G., Maurya, A., Dhiman, N., Kharkwal, H., et al. (2023). Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles. Letters in Drug Design & Discovery, 20( 5), 499-516. doi:10.2174/1570180819666220510133408
NLM
Awasthi R, Singh AK, Mishra G, Maurya A, Dhiman N, Kharkwal H, Sharma B, Jha NK, Dua K, Pinto T de JA, Kulkarni GT. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles [Internet]. Letters in Drug Design & Discovery. 2023 ; 20( 5): 499-516.[citado 2024 jun. 03 ] Available from: https://doi.org/10.2174/1570180819666220510133408
Vancouver
Awasthi R, Singh AK, Mishra G, Maurya A, Dhiman N, Kharkwal H, Sharma B, Jha NK, Dua K, Pinto T de JA, Kulkarni GT. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles [Internet]. Letters in Drug Design & Discovery. 2023 ; 20( 5): 499-516.[citado 2024 jun. 03 ] Available from: https://doi.org/10.2174/1570180819666220510133408
Artigo de periodico
Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling (2023)
Bhat, Asif Ahmad ; Gilhotra, Ritu; Singh, Yogendra; Sharma, Sanjay; Pinto, Terezinha de Jesus Andreoli ; Ferraz, Humberto Gomes ; Singh, Sachin Kumar ; Dua, Kamal ; Gupta, Gaurav
Fonte: Nanomedicine. Unidade: FCF
Assuntos: DOENÇA PULMONAR OBSTRUTIVA CRÔNICA, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BHAT, Asif Ahmad et al. Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling. Nanomedicine, v. 18, n. 7, p. 583-587, 2023Tradução . . Disponível em: https://doi.org/10.2217/nnm-2023-0032. Acesso em: 03 jun. 2024.
APA
Bhat, A. A., Gilhotra, R., Singh, Y., Sharma, S., Pinto, T. de J. A., Ferraz, H. G., et al. (2023). Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling. Nanomedicine, 18( 7), 583-587. doi:10.2217/nnm-2023-0032
NLM
Bhat AA, Gilhotra R, Singh Y, Sharma S, Pinto T de JA, Ferraz HG, Singh SK, Dua K, Gupta G. Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling [Internet]. Nanomedicine. 2023 ; 18( 7): 583-587.[citado 2024 jun. 03 ] Available from: https://doi.org/10.2217/nnm-2023-0032
Vancouver
Bhat AA, Gilhotra R, Singh Y, Sharma S, Pinto T de JA, Ferraz HG, Singh SK, Dua K, Gupta G. Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling [Internet]. Nanomedicine. 2023 ; 18( 7): 583-587.[citado 2024 jun. 03 ] Available from: https://doi.org/10.2217/nnm-2023-0032
Artigo de periodico
Unravelling the role of solid lipid nanoparticles in drug delivery: journey from laboratory to clinical trial (2023)
Harish, Vancha; Mohd, Sharfuddin ; Tewari, Devesh ; Pandey, Narendra Kumar; Vishwas, Sukriti ; Babu, Malakapogu Ravindra ; Salkini, Mohamad Ayman; Rehman, Zia ur; Alotaibi, Jehan Talaq; Alotaibi, Renad Fahad; Alrashed, Fahad Abdulaziz; Prasher, Parteek; Sharma, Nitin; Gupta, Gaurav; Jakhmola, Vikash; Singh, Yogendra; Pinto, Terezinha de Jesus Andreoli ; Paudel, Keshav Raj ; Mittal, Neeraj; Singh, Thakur Gurjeet; Arora, Poonam; Dua, Kamal; Singh, Sachin Kumar
Fonte: Journal of Drug Delivery Science and Technology. Unidade: FCF
Assuntos: NANOPARTÍCULAS, ENSAIO CLÍNICO, BIODISPONIBILIDADE, SOLUBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HARISH, Vancha et al. Unravelling the role of solid lipid nanoparticles in drug delivery: journey from laboratory to clinical trial. Journal of Drug Delivery Science and Technology, v. 85, p. 1-19 art. 104616, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jddst.2023.104616. Acesso em: 03 jun. 2024.
APA
Harish, V., Mohd, S., Tewari, D., Pandey, N. K., Vishwas, S., Babu, M. R., et al. (2023). Unravelling the role of solid lipid nanoparticles in drug delivery: journey from laboratory to clinical trial. Journal of Drug Delivery Science and Technology, 85, 1-19 art. 104616. doi:10.1016/j.jddst.2023.104616
NLM
Harish V, Mohd S, Tewari D, Pandey NK, Vishwas S, Babu MR, Salkini MA, Rehman Z ur, Alotaibi JT, Alotaibi RF, Alrashed FA, Prasher P, Sharma N, Gupta G, Jakhmola V, Singh Y, Pinto T de JA, Paudel KR, Mittal N, Singh TG, Arora P, Dua K, Singh SK. Unravelling the role of solid lipid nanoparticles in drug delivery: journey from laboratory to clinical trial [Internet]. Journal of Drug Delivery Science and Technology. 2023 ; 85 1-19 art. 104616.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.jddst.2023.104616
Vancouver
Harish V, Mohd S, Tewari D, Pandey NK, Vishwas S, Babu MR, Salkini MA, Rehman Z ur, Alotaibi JT, Alotaibi RF, Alrashed FA, Prasher P, Sharma N, Gupta G, Jakhmola V, Singh Y, Pinto T de JA, Paudel KR, Mittal N, Singh TG, Arora P, Dua K, Singh SK. Unravelling the role of solid lipid nanoparticles in drug delivery: journey from laboratory to clinical trial [Internet]. Journal of Drug Delivery Science and Technology. 2023 ; 85 1-19 art. 104616.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.jddst.2023.104616
Artigo de periodico
Reflection about the hemodialysis water microbiological quality in Brazil (2022)
Carvalho, Gabriela Corrêa ; Dua, Kamal ; Gupta, Gaurav ; Bugno, Adriana ; Pinto, Terezinha de Jesus Andreoli
Fonte: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Assuntos: CONTROLE DA QUALIDADE, NEFROPATIAS, MICROBIOLOGIA DA ÁGUA, CONTAMINAÇÃO DA ÁGUA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Gabriela Corrêa et al. Reflection about the hemodialysis water microbiological quality in Brazil. Brazilian Journal of Pharmaceutical Sciences, v. 58, p. 1-13, 2022Tradução . . Disponível em: https://www.scielo.br/j/bjps/a/tg3KLKvmFyyYdmkZ9VxKN4P/?format=pdf&lang=en. Acesso em: 03 jun. 2024.
APA
Carvalho, G. C., Dua, K., Gupta, G., Bugno, A., & Pinto, T. de J. A. (2022). Reflection about the hemodialysis water microbiological quality in Brazil. Brazilian Journal of Pharmaceutical Sciences, 58, 1-13. Recuperado de https://www.scielo.br/j/bjps/a/tg3KLKvmFyyYdmkZ9VxKN4P/?format=pdf&lang=en
NLM
Carvalho GC, Dua K, Gupta G, Bugno A, Pinto T de JA. Reflection about the hemodialysis water microbiological quality in Brazil [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2022 ; 58 1-13.[citado 2024 jun. 03 ] Available from: https://www.scielo.br/j/bjps/a/tg3KLKvmFyyYdmkZ9VxKN4P/?format=pdf&lang=en
Vancouver
Carvalho GC, Dua K, Gupta G, Bugno A, Pinto T de JA. Reflection about the hemodialysis water microbiological quality in Brazil [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2022 ; 58 1-13.[citado 2024 jun. 03 ] Available from: https://www.scielo.br/j/bjps/a/tg3KLKvmFyyYdmkZ9VxKN4P/?format=pdf&lang=en
Artigo de periodico
Setting multivariate and correlated acceptance limits for assessing the conformity of items (2022)
Silva, Ricardo J. N. Bettencourt da ; Lourenço, Felipe Rebello ; Hibber, Brynn
Fonte: Analytical Letters. Unidade: FCF
Assuntos: FARMÁCIA, CADEIAS DE MARKOV
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Ricardo J. N. Bettencourt da e LOURENÇO, Felipe Rebello e HIBBER, Brynn. Setting multivariate and correlated acceptance limits for assessing the conformity of items. Analytical Letters, v. 55, n. 13, p. 2011-2032, 2022Tradução . . Disponível em: https://doi.org/10.1080/00032719.2022.2042549. Acesso em: 03 jun. 2024.
APA
Silva, R. J. N. B. da, Lourenço, F. R., & Hibber, B. (2022). Setting multivariate and correlated acceptance limits for assessing the conformity of items. Analytical Letters, 55( 13), 2011-2032. doi:10.1080/00032719.2022.2042549
NLM
Silva RJNB da, Lourenço FR, Hibber B. Setting multivariate and correlated acceptance limits for assessing the conformity of items [Internet]. Analytical Letters. 2022 ; 55( 13): 2011-2032.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1080/00032719.2022.2042549
Vancouver
Silva RJNB da, Lourenço FR, Hibber B. Setting multivariate and correlated acceptance limits for assessing the conformity of items [Internet]. Analytical Letters. 2022 ; 55( 13): 2011-2032.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1080/00032719.2022.2042549
Artigo de periodico
Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems (2022)
Prasher, Parteek ; Sharma, Mousmee ; Singh, Sachin Kumar ; Gulati, Monica ; Jha, Niraj Kumar ; Gupta, Piyush Kumar ; Gupta, Gaurav ; Chellappan, Dinesh Kumar ; Zacconi, Flavia ; Pinto, Terezinha de Jesus Andreoli ; Chan, Yinghan ; Liu, Gang; Paudel, Keshav Raj ; Hansbro, Philip Michael ; Oliver, Brian Gregory George; Dua, Kamal
Fonte: Chemico Biological Interactions. Unidade: FCF
Assuntos: DOENÇAS RESPIRATÓRIAS, MUCO, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRASHER, Parteek et al. Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems. Chemico Biological Interactions, v. 365, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.cbi.2022.110048. Acesso em: 03 jun. 2024.
APA
Prasher, P., Sharma, M., Singh, S. K., Gulati, M., Jha, N. K., Gupta, P. K., et al. (2022). Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems. Chemico Biological Interactions, 365, 1-14. doi:10.1016/j.cbi.2022.110048
NLM
Prasher P, Sharma M, Singh SK, Gulati M, Jha NK, Gupta PK, Gupta G, Chellappan DK, Zacconi F, Pinto T de JA, Chan Y, Liu G, Paudel KR, Hansbro PM, Oliver BGG, Dua K. Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems [Internet]. Chemico Biological Interactions. 2022 ; 365 1-14.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.cbi.2022.110048
Vancouver
Prasher P, Sharma M, Singh SK, Gulati M, Jha NK, Gupta PK, Gupta G, Chellappan DK, Zacconi F, Pinto T de JA, Chan Y, Liu G, Paudel KR, Hansbro PM, Oliver BGG, Dua K. Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems [Internet]. Chemico Biological Interactions. 2022 ; 365 1-14.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.cbi.2022.110048
Artigo de periodico
Multidrug-resistant Klebsiella pneumoniae: a retrospective study in Manaus, Brazil (2022)
Silva, Rafael Nakamura ; Cerdeira, Louise Teixeira ; Silva, Mariana Oliveira ; Costa, Karen Regina Carim da; Pereira, Elder Sano ; Araujo, Bruna Fuga; Silva, Quézia Moura da ; Esposito, Fernanda Ribeiro dos Santos ; Huenuman, Nilton Erbet Lincopan ; Wyres, Kelly; Silva, André Pitondo
Fonte: Archives of Microbiology. Unidades: ICB, FCF
Assuntos: MICROBIOLOGIA, GENÉTICA BACTERIANA, BACTÉRIAS ANAERÓBICAS GRAM-NEGATIVAS, ENTEROBACTERIACEAE, INFECÇÕES BACTERIANAS GRAM-NEGATIVAS, VIRULÊNCIA, ESTUDOS RETROSPECTIVOS, TESTES DE SENSIBILIDADE MICROBIANA, ANTIBIÓTICOS, EPIDEMIOLOGIA, INFECÇÃO HOSPITALAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Rafael Nakamura et al. Multidrug-resistant Klebsiella pneumoniae: a retrospective study in Manaus, Brazil. Archives of Microbiology, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00203-022-02813-0. Acesso em: 03 jun. 2024.
APA
Silva, R. N., Cerdeira, L. T., Silva, M. O., Costa, K. R. C. da, Pereira, E. S., Araujo, B. F., et al. (2022). Multidrug-resistant Klebsiella pneumoniae: a retrospective study in Manaus, Brazil. Archives of Microbiology, 1-8. doi:10.1007/s00203-022-02813-0
NLM
Silva RN, Cerdeira LT, Silva MO, Costa KRC da, Pereira ES, Araujo BF, Silva QM da, Esposito FR dos S, Huenuman NEL, Wyres K, Silva AP. Multidrug-resistant Klebsiella pneumoniae: a retrospective study in Manaus, Brazil [Internet]. Archives of Microbiology. 2022 ; 1-8.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s00203-022-02813-0
Vancouver
Silva RN, Cerdeira LT, Silva MO, Costa KRC da, Pereira ES, Araujo BF, Silva QM da, Esposito FR dos S, Huenuman NEL, Wyres K, Silva AP. Multidrug-resistant Klebsiella pneumoniae: a retrospective study in Manaus, Brazil [Internet]. Archives of Microbiology. 2022 ; 1-8.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s00203-022-02813-0
Artigo de periodico
Chikungunya patient transcriptional signatures faithfully recapitulated in a C57BL/6J mouse model (2022)
Bishop, Cameron R; Caten, Felipe Ten ; Nakaya, Helder Takashi Imoto ; Suhrbier, Andreas
Fonte: Frontiers in Immunology. Unidade: FCF
Assuntos: VÍRUS CHIKUNGUNYA, BIOINFORMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BISHOP, Cameron R et al. Chikungunya patient transcriptional signatures faithfully recapitulated in a C57BL/6J mouse model. Frontiers in Immunology, v. 13, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.1092370. Acesso em: 03 jun. 2024.
APA
Bishop, C. R., Caten, F. T., Nakaya, H. T. I., & Suhrbier, A. (2022). Chikungunya patient transcriptional signatures faithfully recapitulated in a C57BL/6J mouse model. Frontiers in Immunology, 13, 1-16. doi:10.3389/fimmu.2022.1092370
NLM
Bishop CR, Caten FT, Nakaya HTI, Suhrbier A. Chikungunya patient transcriptional signatures faithfully recapitulated in a C57BL/6J mouse model [Internet]. Frontiers in Immunology. 2022 ; 13 1-16.[citado 2024 jun. 03 ] Available from: https://doi.org/10.3389/fimmu.2022.1092370
Vancouver
Bishop CR, Caten FT, Nakaya HTI, Suhrbier A. Chikungunya patient transcriptional signatures faithfully recapitulated in a C57BL/6J mouse model [Internet]. Frontiers in Immunology. 2022 ; 13 1-16.[citado 2024 jun. 03 ] Available from: https://doi.org/10.3389/fimmu.2022.1092370
Artigo de periodico
Detection of IncN-pST15 One-Health plasmid harboring blaKPC-2 in a hypermucoviscous Klebsiella pneumoniae CG258 isolated from an infected dog, Brazil (2021)
Sellera, Fábio Parra ; Fuga, Bruna ; Fontana, Herrison Yoshiki Yocida ; Esposito, Fernanda Ribeiro dos Santos ; Cardoso, Brenda ; Konno, Sibele; Berl, Carla; Cappelanes, Mariana H.; Cortez, Marcia; Ikeda, Marcelo ; Souza, Cesar Martins de; Cerdeira, Louise Teixeira ; Lincopan, Nilton
Fonte: Transboundary and Emerging Diseases. Unidades: ICB, FMVZ, FCF
Assuntos: ANIMAIS DOMÉSTICOS, PATOGENIA ANIMAL, PLASMÍDEOS, GENÉTICA ANIMAL, INFECÇÕES BACTERIANAS GRAM-NEGATIVAS, CÃES, RESISTÊNCIA GENÉTICA ANIMAL, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SELLERA, Fábio Parra et al. Detection of IncN-pST15 One-Health plasmid harboring blaKPC-2 in a hypermucoviscous Klebsiella pneumoniae CG258 isolated from an infected dog, Brazil. Transboundary and Emerging Diseases, v. 68, n. 6, p. 3083-3088, 2021Tradução . . Disponível em: https://doi.org/10.1111/tbed.14006. Acesso em: 03 jun. 2024.
APA
Sellera, F. P., Fuga, B., Fontana, H. Y. Y., Esposito, F. R. dos S., Cardoso, B., Konno, S., et al. (2021). Detection of IncN-pST15 One-Health plasmid harboring blaKPC-2 in a hypermucoviscous Klebsiella pneumoniae CG258 isolated from an infected dog, Brazil. Transboundary and Emerging Diseases, 68( 6), 3083-3088. doi:10.1111/tbed.14006
NLM
Sellera FP, Fuga B, Fontana HYY, Esposito FR dos S, Cardoso B, Konno S, Berl C, Cappelanes MH, Cortez M, Ikeda M, Souza CM de, Cerdeira LT, Lincopan N. Detection of IncN-pST15 One-Health plasmid harboring blaKPC-2 in a hypermucoviscous Klebsiella pneumoniae CG258 isolated from an infected dog, Brazil [Internet]. Transboundary and Emerging Diseases. 2021 ; 68( 6): 3083-3088.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1111/tbed.14006
Vancouver
Sellera FP, Fuga B, Fontana HYY, Esposito FR dos S, Cardoso B, Konno S, Berl C, Cappelanes MH, Cortez M, Ikeda M, Souza CM de, Cerdeira LT, Lincopan N. Detection of IncN-pST15 One-Health plasmid harboring blaKPC-2 in a hypermucoviscous Klebsiella pneumoniae CG258 isolated from an infected dog, Brazil [Internet]. Transboundary and Emerging Diseases. 2021 ; 68( 6): 3083-3088.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1111/tbed.14006

Unidades USP

ReP

Filtros

Tipo de material

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Editora

Nome do evento

País de publicação

Grupo de pesquisa

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos